Compare ALGS & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALGS | PRT |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 41.4M |
| IPO Year | 2020 | N/A |
| Metric | ALGS | PRT |
|---|---|---|
| Price | $6.37 | $2.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 188.6K | 55.0K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.09% |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $2.61 |
| 52 Week High | $13.69 | $4.28 |
| Indicator | ALGS | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 36.40 |
| Support Level | N/A | N/A |
| Resistance Level | $8.03 | $3.57 |
| Average True Range (ATR) | 0.72 | 0.13 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 13.33 | 9.59 |
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.